Summary & Overview
HCPCS G9298: Preoperative Venous Thromboembolic and Cardiovascular Risk Evaluation
HCPCS Level II code G9298 captures a focused preoperative evaluation for venous thromboembolic and cardiovascular risk factors performed within 30 days before a procedure. This code reflects attention to patient histories of deep vein thrombosis, pulmonary embolism, myocardial infarction, arrhythmia, and stroke — conditions that can materially affect perioperative planning and patient safety. Nationally, standardized reporting of such evaluations supports surgical risk stratification, appropriate prophylaxis decisions, and communication across care teams.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise summary of the code’s clinical intent, typical sites of service, common modifiers associated with billing of this service, and where available, payer coverage contexts. The publication also outlines benchmarking elements, policy considerations affecting preoperative evaluations, and clinical context that informs appropriate use.
Data not available in the input includes specific ICD-10 diagnoses, associated taxonomies, and related billing codes.
Billing Code Overview
HCPCS Level II code G9298 describes evaluation of patients for venous thromboembolic and cardiovascular risk factors within 30 days prior to a procedure. The description cites assessment of histories such as deep vein thrombosis (dvt), pulmonary embolism (pe), myocardial infarction (mi), arrhythmia, and stroke.
-
Service type: Pre-procedural cardiovascular and thromboembolic risk evaluation
-
Typical site of service: Outpatient clinic or preoperative evaluation setting (including procedural clinics and ambulatory surgical centers)
Data not available in the input for associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with a history of atrial fibrillation and prior deep vein thrombosis is scheduled for an elective total knee arthroplasty. Within 30 days prior to the procedure the preoperative clinic performs a focused evaluation for venous thromboembolic and cardiovascular risk factors. The evaluation includes a targeted history (prior DVT/PE, myocardial infarction, arrhythmias, stroke), review of current anticoagulant/antiplatelet therapy, medication reconciliation, baseline vital signs, focused cardiopulmonary exam, and review of relevant recent diagnostic testing (e.g., ECG, echocardiogram, duplex ultrasound reports if available). The clinician documents risk assessment, perioperative anticoagulation plan, and any recommendations for perioperative monitoring or prophylaxis.
A typical workflow: the patient is seen in preoperative clinic 7–21 days before surgery; the clinician reviews records and medications, performs the focused assessment, documents findings and risk stratification in the medical record, communicates the plan to the surgical and anesthesia teams, and places orders for appropriate perioperative prophylaxis or monitoring. If findings change within 30 days (new arrhythmia, recurrent DVT, or recent cardiac event), the evaluation is updated and re-documented prior to the procedure.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased Procedural Services | When work required is substantially greater than typical for the service due to complex preoperative evaluation for thromboembolic/cardiac risk. |